Market Place
Sourcing Support
Switch Study Shows Stability With Cobenfy In Patients
28 Mar 2026 //
PHARMIWEB
AI Transforms Pharma`s Financials Beyond Drug Discovery
11 Feb 2026 //
BIOSPACE
BMS, J&J Factor In HCP Education Before Milvexian Data Drop
03 Feb 2026 //
FIERCE PHARMA
Microsoft, Bristol Myers Advance AI Lung Cancer Detection
20 Jan 2026 //
BUSINESSWIRE
BMS Cooks Up Schizophrenia Stigma-Busting Push With Gail Simmons
13 Oct 2025 //
FIERCE PHARMA
BMS & Gail Launch Initiative to Reduce Schizophrenia Stigma
10 Oct 2025 //
BUSINESSWIRE
Biocartis NV Gets FDA Approval for Idylla™ CDx MSI Test
15 Sep 2025 //
GLOBENEWSWIRE
FDA Approves Agilent MMR IHC Panel for Colorectal Cancer
20 Aug 2025 //
BUSINESSWIRE
Markey Researchers Get $6.8M For Lung Cancer Screening Model
06 Jun 2025 //
ACCESSWIRE
Strengthening Local Health System Capacity for Better Care
07 May 2025 //
ACCESSWIRE
S1P Receptor Modulators Face Uncertain Future In Crohn’s Disease
14 Oct 2024 //
EXPRESSPHARMA
LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus
03 Jul 2024 //
PR NEWSWIRE
US study suggests BMS’ cancer drug could target Parkinson’s-causing protein
20 Jun 2024 //
PHARMATIMES
Analysts predict myeloma market will hit $33B by 2030
05 Jun 2024 //
FIERCE PHARMA
GSK brings Johns Hopkins prof and Blade co-founder on board; & more
27 Oct 2021 //
ENDPTS
T-cell player Neogene bolsters U.S. team, adding BMS vet as COO
26 May 2021 //
FIERCEBIOTECH
Can a rare immune cell offer the key to slowing down senescence? A Bay Area
11 May 2021 //
ENDPTS
5 years later, CAR-T pioneer Kymriah offers jaw-dropping evidence
18 Feb 2021 //
ENDPTS
Physician Views results: BMS’s first-in-class Tyk-2 set to threaten Otezla
10 Feb 2021 //
FIRSTWORDPHARMA
Covid-19 claims another PDUFA victim as GlaxoSmithKline pushes back planned
20 Jan 2021 //
ENDPTS
A booming Dragonfly is taking its TriNKETs to Copenhagen as the Bristol Myers
06 Jul 2020 //
ENDPTS
COVID drives demand for BMS` Eliquis but could hurt Opdivo sales
07 May 2020 //
FIERCE PHARMA
Battling low expectations and goliath rivals, Regeneron/Sanofi add +ve Libtayo
04 May 2020 //
ENDPTS
The first big hurdle on the Celgene CVR arrives today. Can BMY`s clear a low bar
25 Mar 2020 //
ENDPTS
Here are 2020`s 11 blockbuster drug launches
12 Feb 2020 //
FIERCE PHARMA
Big Pharma drove 2019 dealmaking, but in 2020, count biotech in
13 Jan 2020 //
FIERCE PHARMA
CAR-T therapies shine at ASH
09 Dec 2019 //
PHARMATIMES
Reviving tired T cells to improve immuno-oncology treatments
17 Jun 2019 //
FIERCE BIOTECH
Nektar, Bristol combo drug shows signs of tumor reduction in cancer patients
15 Feb 2019 //
ECONOMIC TIMES
Bayer, Orion prostate cancer drug cuts risk of metastasis by > 50%, study
15 Feb 2019 //
ENDPTS
Keytruda combo outshines Opdivo in kidney cancer
13 Feb 2019 //
PM LIVE
Sanofi’s R&D remodeling spotlights what’s hot in oncology today
09 Feb 2019 //
ENDPTS
Gilead takes an $820M hit after axing a Kite CAR-T
04 Feb 2019 //
ENDPTS
JPM 2019: Lilly buys Loxo, Pfizer’s biosimilar bundle and $22 coffee
22 Jan 2019 //
BIOPROCESS INTL
Celgene strikes Obsidian deal to boost CAR-T options
19 Jan 2019 //
FIERCE BIOTECH
Forma axes discovery biology team as part of a broader reorganization
18 Jan 2019 //
ENDPTS
BMS Buyout Not Stopping Celgene from Collaborating with Kyn, Obsidian
18 Jan 2019 //
GEN ENG NEWS
A Planned Spinoff Of Cancer Vaccines At Generex
14 Jan 2019 //
SEEKING ALPHA
M&A, IPOs and VC raises: Biotech, medtech execs look to 2019
12 Jan 2019 //
FIERCE BIOTECH
New drug screen uncovers small-molecule candidates for immuno-oncology
11 Jan 2019 //
FIERCE BIOTECH
IPO bonanza as biotechs get in while the iron’s hot
09 Jan 2019 //
FIERCE BIOTECH
FDA plans to create a new office to leverage cutting-edge science
05 Jan 2019 //
STAT NEWS
The 20 Hottest Pipeline Drugs to Watch in 2019
03 Jan 2019 //
BIOSPACE
Bristol-Myers Squibb’s Sprycel (dasatinib) Tablets Approved
03 Jan 2019 //
BUSINESSWIRE
Bristol-Myers Squibb nears $1.6B sale of OTC unit Upsa to Taisho: report
17 Dec 2018 //
FIERCE PHARMA
Sue Dillon, Karyn O’Neil steer fledgling Aro Biotherapeutics to $13M debut
11 Dec 2018 //
ENDPTS
BMS, Vedanta Biosciences enter clinical collab to evaluate Opdivo+VE800
11 Dec 2018 //
PHARMABIZ
Bristol-Myers Squibb & Vedanta Collaborate to Evaluate Nivolumab, VE800
08 Dec 2018 //
BUSINESSWIRE
The number of I/O cancer drugs in the clinic continues to swell at an explosive pace
30 Nov 2018 //
ENDPTS
Merck KGaA Gets Into Deeper Trouble In Immune Checkpoint Inhibition
22 Nov 2018 //
SEEKING ALPHA
Pfizer, Merck KGaA`s Bavencio flunks another trial in Ovarian Cancer
20 Nov 2018 //
FIERCE PHARMA
Nektar nabs Genentech I-O leader Wei Lin to head up its oncology programs
14 Nov 2018 //
FIERCE BIOTECH
SITC18: Nektar’s NKTR-214 holds steady with BMS’ Opdivo
10 Nov 2018 //
FIERCE BIOTECH
Platelet Immunotherapy Riding On Blood Stem Cell Delivery Trucks
26 Oct 2018 //
FORBES
Opdivo-Yervoy combi Demonstrates Durable 4Y Survival in Adv Melanoma
22 Oct 2018 //
PRESS RELEASE
Opdivo-Yervoy combination Demonstrates Durable 4Y Survival in Adv Melanoma
22 Oct 2018 //
PRESS RELEASE
Opdivo-Yervoy Combination Results in Previously Untreated Adv RCC
22 Oct 2018 //
PRESS RELEASE
Opdivo-Yervoy combi Demonstrates Durable 4Y Survival in Adv Melanoma
22 Oct 2018 //
PRESS RELEASE
Opdivo-Yervoy combination Demonstrates Durable 4Y Survival in Adv Melanoma
22 Oct 2018 //
PRESS RELEASE
Opdivo-Yervoy Combination Results in Previously Untreated Adv RCC
22 Oct 2018 //
PRESS RELEASE
